Conditions: Japanese Patients With ALS
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 9
Healthy volunteers: no

Brief summary:
To evaluate the pharmacokinetics of single doses of edaravone oral suspension in Patients with Amyotrophic Lateral Sclerosis

Detailed description:

Arms:
arm 1: Patients receive the edaravone oral suspension.

Interventions: intervention 1: MT-1186
Intervention descriptions: intervention 1: Suspension

Protocol document:
Prot_000.pdf: 





















































































































SAP_001.pdf: